ArticleFrontiers in pharmacology2025
Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma.
Jipin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleFrontiers in pharmacology2025
Jipin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.